The legal library gives you easy access to the FTC’s case information and other official legal, policy, and guidance documents.
1202013 Informal Interpretation
1202014 Informal Interpretation
1202014 Informal Interpretation
20120529: Fidelity National Financial, Inc.; O'Charley's Inc.
20120524: Roger S. Penske; Roger S. Penske
20120523: KRG Capital Fund IV, L.P.; Frontenac VIII Limited Partnership
20120522: Innovative Interfaces Holdings Ltd.; Gerald M. Kline
20120502: CVS Caremark Corporation; Health Net, Inc.
JGRD, Inc., also d/b/a Voiceblaze.com and VoiceBlaze, et al.
20120469: Raymond James Financial, Inc.; Regions Financial Corp.
20120338: TE Connectivity Ltd.; Wendel SA
20120519: Molibdenos y Metales S.A.; Molycorp, Inc.
1202011 Informal Interpretation
1202011 Informal Interpretation
Omnicare, Inc., a corporation, In the Matter of
The Commission issued a complaint to block Omnicare, Inc.'s hostile acquisition of rival long-term care pharmacy provider PharMerica Corporation, alleging that the combination of the two largest U.S. long-term care pharmacies would harm competition and enable Omnicare to raise the price of drugs for Medicare Part D consumers and others. In its complaint, the FTC charges that a deal combining Omnicare and PharMerica would significantly increase Omnicare's already substantial bargaining leverage by dramatically increasing the number of skilled nursing facilities, known as SNFs, that receive long-term care pharmacy services from the company. Due to its substantial market share, the FTC alleges that the combined firm likely would be a "must have" for Medicare Part D prescription drug plans, which are responsible for providing subsidized prescription drug benefit coverage for most SNF residents and other Medicare beneficiaries. On 2/23/2012, the FTC dismissed the complaint in light of Omnicare's decision to abandon the proposed transaction.